Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects

Chest

Volumn 128, Issue 5, 2005, Pages 3537-3544

  Journois, Didier ^a   Baufreton, Christophe ^c   Mauriat, Philippe ^b   Pouard, Philippe ^b   Vouhé, Pascal ^c   Safran, Denis ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Laennec Necker ^*  (France)

Author keywords

Cardiopulmonary bypass; Congenital; Down syndrome complications; Heart defects; Heart septal defects; Hypertension etiology; Nitric oxide administration and dosage; Pulmonary hypertension; Surgery; Therapeutic nitric oxide

Indexed keywords

NITRIC OXIDE;

ARTICLE; ATRIOVENTRICULAR CANAL; ATRIOVENTRICULAR CANAL DEFECT; CLINICAL OBSERVATION; CONFIDENCE INTERVAL; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; HUMAN; INFANT; INFECTION; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; LUNG PRESSURE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; POSTOPERATIVE PERIOD; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 28144441707     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.5.3537     Document Type: Article

References (36)

1. Hopkins RA, Bull C, Haworth S, et al. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5:628-634
2. Abman SH, Kinsella JP, Schaffer MS, et al. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993; 92:606-609
3. Roberts JD Jr, Fineman JR, Morin FC III, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn: The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336:605-610
4. Foubert L, Latimer R, Oduro A, et al. Use of inhaled nitric oxide to reduce pulmonary hypertension after heart transplantation. J Cardiothorac Vasc Anesth 1993; 7:506-507
5. Journois D, Pouard P, Mauriat P, et al. Inhaled nitric oxide as a therapy of pulmonary hypertension following surgery for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107:1129-1135
6. Girard C, Neidecker J, Laroux MC, et al. Inhaled nitric oxide in pulmonary hypertension after total repair of total anomalous pulmonary venous return. J Thorac Cardiovasc Surg 1993; 106:369
7. Russell IA, Zwass MS, Fineman JR, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998; 87:46-51
8. Miller OI, Tang SF, Keech A, et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000; 356:1464-1469
9. Goldman AP, Delius RE, Deanfield JE, et al. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg 1995; 60:300-305
10. Muhiudeen I, Robertson D, Silverman N, et al. Intraoperative echocardiography for evaluation of congenital heart detects in infants and children. Anesthesiology 1992; 76:165-172
11. Hanley FL, Fenton KN, Jonas RA, et al. Surgical repair of complete atrioventricular canal defects in infancy: twenty-year trends. J Thorac Cardiovasc Surg 1993; 106:387-394
12. Studer M, Blackstone EH, Kirklin JW, et al. Determinants of early and late results of repair of atrioventricular septal defects. J Thorac Cardiovasc Surg 1982; 84:523-542
13. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
14. Zobel G, Rodl S, Rigler B, et al. Prospective evaluation of clinical scoring systems in infants and children with cardiopulmonary insufficiency after cardiac surgery. J Cardiovasc Surg (Torino) 1993; 34:333-337
15. Pietro D, Bresh KL, Shulman R, et al. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl J Med 1984; 310:1032-1034
16. 1: a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg 1985; 89:567-572
17. Kirmse M, Hess D, Fujino Y, et al. Delivery of inhaled nitric oxide using the Ohmeda Inovent Delivery System. Chest 1998; 113:1650-1657
18. Norusis MJ. Advanced statistics student guide. Chicago, IL: SPSS, 1990
19. Miettinen O. Stratification by a multivariate confounder score. Am J Epidemiol 1976; 104:609-620
20. Haydar A, Mauriat P, Journois D, et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992; 340:1545
21. Roberts J, Lang P, Bigatello L, et al. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-453
22. Sellden H, Winberg P, Gustafsson LE, et al. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant. Anesthesiology 1993; 78:577-580
23. Berner M, Beghetti M, Ricou B, et al. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993; 19:75-77
24. Okamoto K, Hamaguchi M, Kukita I, et al. Efficacy of inhaled nitric oxide in children with ARDS. Chest 1998; 114:827-833
25. Baldauf M, Silver P, Sagy M. Evaluating the validity of responsiveness to inhaled nitric oxide in pediatric patients with ARDS: an analytic tool. Chest 2001; 119:1166-1172
26. Goldman AP, Tasker RC, Hosiasson S, et al. Early response to inhaled nitric oxide and its relationship to outcome in children with severe hypoxemic respiratory failure. Chest 1997; 112:752-758
27. Miettinen OS. Matching and design efficiency in retrospective studies. Am J Epidemiol 1970; 91:111-118
28. Roberts J, Polaner D, Lang P, et al. Inhaled nitric oxide in persistant pulmonary hypertension of the newborn. Lancet 1992; 340:818-819
29. Kinsella J. Low-close inhalational nitric oxide in persistant pulmonary hypertension of the newborn. Lancet 1992; 340:819-820
30. Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down's syndrome. Acta Paediatr Scand 1975; 64:322-326
31. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
32. Roberts J, Chen T, Kawai N, et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993; 72:246-254
33. Puybasset L, Stewart T, Rouby JJ, et al. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 1994; 80:1254-1267
34. Yosbibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentration in patients with pulmonary hypertension associated with congenital heart defects: evidence for increased production of endothelin in pulmonary circulation. Circulation 1991; 84:2280-2285
35. Wheller J, George B, Muller D, et al. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1980; 60:1640-1664
36. Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995; 107:1107-1115